Science Day mRNA pipeline updates and short squeeze drive Moderna

 

Science Day mRNA pipeline updates and short squeeze drive Moderna's 11% surge

• MRNA up ~11.37% on July 2, 2026 to ~$81, hitting 52-week highs
• Builds on June 25 Science Day highlighting cancer, rare disease, autoimmune, and AI-powered mRNA programs
• Stock rallied over 40% in June and 135-174% YTD amid pipeline optimism beyond COVID vaccines
• Short squeeze amplified gains as positive sentiment on new strategic focus intensified
• Recent Lancet review (June 30) confirming mRNA vaccines' strong safety profile provided further tailwind
• Analyst and retail chatter noted momentum extension with possible Cramer commentary adding fuel
• No single new announcement on July 2 but clear digestion of prior positive events

https://finviz.com/stock?t=MRNA&p=d